Barna Fodor

Dr. Barna Fodor


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2007 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MWMelanie Wissmann
Melanie Wissmann
NYNa Yin
Na Yin
JMJudith M. Müller
Judith M. Müller
HGHolger Greschik
Holger Greschik
BFBarna Fodor
Barna Fodor
RSRoland Schüle
Roland Schüle

31 May 2006 in Genes & Development
Verified
Journal Article
Closed access
PDF file
BFBarna Fodor
Barna Fodor
SKStefan Kubicek
Stefan Kubicek
MYMasato Yonezawa
Masato Yonezawa
RORoderick J. O’sUllivan
Roderick J. O’sUllivan
RSRoopsha Sengupta
Roopsha Sengupta
TJThomas Jenuwein
Thomas Jenuwein
Histone lysine trimethyl states represent some of the most robust epigenetic modifications in eukaryotic chromatin. Using a candidate approach, we identified the subgroup of murine Jmjd2 proteins to antagonize H3K9me3 at pericentric heterochromatin. H3K27me3 and H4K20me3 marks are not impaired in inducible Jmjd2b-GFP cell lines, but Jmjd2b also reduces H3K36 methylation. Since recombinant Jmjd2b appears as a very poor enzyme, we applied metabolic labeling with heavy methyl groups to demonstrate Jmjd2b-mediated removal of chromosomal H3K9me3 as an active process that occurs well before replication of chromatin. These data reveal that certain members of the jmjC class of hydroxylases can work in a pathway that actively antagonizes a histone lysine trimethyl state.

10 November 2010 in Annual Review of Cell and Developmental Biology
Verified
Journal Article
Closed access
BFBarna Fodor
Barna Fodor
NSNicholas Shukeir
Nicholas Shukeir
GRGunter Reuter
Gunter Reuter
TJThomas Jenuwein
Thomas Jenuwein
Genetic screens in Drosophila have been instrumental in distinguishing approximately 390 loci involved in position effect variegation and heterochromatin stabilization. Most of the identified genes [so-called Su(var) and E(var) genes] are also conserved in mammals, where more than 50 of their gene products are known to localize to constitutive heterochromatin. From these proteins, approximately 12 core heterochromatin components can be inferred. In addition, there are approximately 30 additional Su(var) and 10 E(var) factors that can, under distinct developmental options, interchange with constitutive heterochromatin and participate in the partitioning of the genome into repressed and active chromatin domains. A significant fraction of the Su(var) and E(var) factors are enzymes that respond to environmental and metabolic signals, thereby allowing both the variation and propagation of epigenetic states to a dynamic chromatin template. Moreover, the misregulation of human SU(VAR) and E(VAR) function can advance cancer and many other human diseases including more complex disorders. As such, mammalian Su(var) and E(var) genes and their products provide a rich source of novel targets for diagnosis of and pharmaceutical intervention in many human diseases.

5 July 2024 in Science
Verified
Journal Article
Closed access
PTPamela Y. Ting
Pamela Y. Ting
SBSneha Borikar
Sneha Borikar
JKJohn Ryan Kerrigan
John Ryan Kerrigan
NTNoel M. Thomsen
Noel M. Thomsen
EAEamon Aghania
Eamon Aghania
JBJames E. Bradner
James E. Bradner
Sickle cell disease (SCD) is a prevalent, life-threatening condition attributable to a heritable mutation in β-hemoglobin. Therapeutic induction of fetal hemoglobin (HbF) can ameliorate disease complications and has been intently pursued. However, safe and effective small-molecule inducers of HbF remain elusive. We report the discovery of dWIZ-1 and dWIZ-2, molecular glue degraders of the WIZ transcription factor that robustly induce HbF in erythroblasts. Phenotypic screening of a cereblon (CRBN)–biased chemical library revealed WIZ as a previously unknown repressor of HbF. WIZ degradation is mediated by recruitment of WIZ(ZF7) to CRBN by dWIZ-1, as resolved by crystallography of the ternary complex. Pharmacological degradation of WIZ was well tolerated and induced HbF in humanized mice and cynomolgus monkeys. These findings establish WIZ degradation as a globally accessible therapeutic strategy for SCD.

1 October 2015 in SLAS Discovery
Verified
Journal Article
Open access
MKMarkus Kaufmann
Markus Kaufmann
ASAnsgar Schuffenhauer
Ansgar Schuffenhauer
IFIsabelle Fruh
Isabelle Fruh
JKJessica Klein
Jessica Klein
ATAnke Thiemeyer
Anke Thiemeyer
ACAmanda Cobos-Correa
Amanda Cobos-Correa
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.

1 December 2009 in Biophysical Journal
Verified
Journal Article
Closed access
KMKatharina P. Müller
Katharina P. Müller
FEFabian Erdel
Fabian Erdel
MCMaïwen Caudron-Herger
Maïwen Caudron-Herger
CMCaroline Marth
Caroline Marth
BFBarna Fodor
Barna Fodor
KRKarsten Rippe
Karsten Rippe